FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Entrada Therapeutics DMD Drug Remains on Hold

[ Price : $8.95]

Entrada Therapeutics says an ongoing clinical hold against the companys Phase 1 trial of ENTR-601-44 in Duchenne muscular dystroph...

Buprenex Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Indiviors Buprenex (buprenorphine HCl) injection, 0.3 mg/mL, was not withdrawn due to...

Covid-19 Treatment, Prevention Products Guidance

[ Price : $8.95]

FDA publishes an immediately-in-effect guidance on developing drugs and biologics to prevent or treat some Covid-19.

Guide on GLP Study Translation

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Translation of GLP Study Reports: Questions and Answers.

FDA Declines to Ban Some Music in DTC Ads

[ Price : $8.95]

FDA declines to ban music in all DTC ads during the presentation of risk information.

Masimo Medical Watch Cleared by FDA

[ Price : $8.95]

FDA clears a Masimo 510(k) for Masimo W1 medical watch for providing continuous real-time oxygen saturation and pulse rate for ove...

VAERS Has A Proven Track Record: FDA/CDC

[ Price : $8.95]

In a likely attempt to rebut a critical BMJ investigation, FDA and CDC officials explain, defend, and praise the Vaccine Adverse E...

SCOTUS Should Hear Mifepristone Appeal: FDA

[ Price : $8.95]

A brief filed by the U.S. Solicitor General on behalf of FDA calls on the Supreme Court to hear the agencys appeal of a 5th Circui...

Objectionable Conditions in 2 Clinical Trials

[ Price : $8.95]

FDA warns Dr. Melanie Hoppers/Physicians Quality Care in Jackson, TN, about violations in two clinical investigations at her study...

Do Postmarket Studies Need Public Funds?: Califf

[ Price : $8.95]

FDA commissioner Robert Califf says there have been discussions about whether public funding should be used to support some key po...